Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children

S A Madhi; M Venter; A Madhi; M K Petersen; K P Klugman

doi:10.1097/00006454-200102000-00010

Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children

Pediatr Infect Dis J. 2001 Feb;20(2):164-70. doi: 10.1097/00006454-200102000-00010.

Authors

S A Madhi¹, M Venter, A Madhi, M K Petersen, K P Klugman

Affiliation

¹ South African Institute for Medical Research/University of the Witwatersrand/Medical Research Council Pneumococcal Diseases Research Unit, Johannesburg.

PMID: 11224836
DOI: 10.1097/00006454-200102000-00010

Abstract

Background: Respiratory syncytial virus (RSV) causes increased morbidity and mortality in immunocompromised children. The outcome of RSV-associated lower respiratory tract infections (LRTI) in HIV-infected children, is less well described.

Methods: Children from a prospective study evaluating the etiology of

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Antibodies, Monoclonal
Bacteremia / complications
Child, Preschool
Cohort Studies
Female
Fever
HIV Infections / complications*
HIV Infections / epidemiology
HIV Infections / mortality
HIV-1*
Humans
Immunocompromised Host
Infant
Infant, Newborn
Leukocyte Count
Male
Pneumonia / complications
Prevalence
Prospective Studies
Respiratory Syncytial Virus Infections / complications*
Respiratory Syncytial Virus Infections / epidemiology
Respiratory Syncytial Virus Infections / mortality
Respiratory Tract Infections / complications*
Respiratory Tract Infections / epidemiology
Respiratory Tract Infections / virology
Reverse Transcriptase Polymerase Chain Reaction
Risk Factors
Seasons
South Africa / epidemiology

Substances

Antibodies, Monoclonal